Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease
Clinical trial NCT00702689 · COMPLETED
Trial details
- NCT number
- NCT00702689
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-15
- Primary completion
- 2011-05-18
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.